Artificial intelligence a double-edged sword for authors –⁠ the pitfalls of its use

Czech version

Authors: Jaroslav A. Hubáček ^1,2
Authors‘ workplace: Centrum experimentální medicíny IKEM, Praha ¹; III. interní klinika – endokrinologie a metabolismu 1. LF UK a VFN v Praze ²
Published in: AtheroRev 2025; 10(3): 193-195
Category:

Labels

Angiology Diabetology Internal medicine Cardiology General practitioner for adults

Editorial

Cardio-renal-metabolic syndrome: statement by the Czech Society for Atherosclerosis Committee – year 2025

The event is not a coincidence, or the need for long-term and effective cardiovascular risk control

“RNA Therapy 101”: The basics of RNA therapy in questions and answers

Bempedoic acid – recommended by guidelines, confirmed in practice

Interactions (not only between genes and the environment) and cardiovascular disease

Evinacumab – one year of experience in patients with homozygous familial hypercholesterolemia: case reports

Comprehensive lipid-lowering therapy and cardiovascular risk reduction: a case report

Update to ESC/EAS recommendations for dyslipidemia: what‘s new?

Research on remarkable articles from international literature

Supplementum online: 29th congress on atherosclerosis, 4th – 6th december 2025, Olomouc

Article was published in

Athero Review

2025 Issue 3